Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Health Catalyst, Inc.
Report date June 01, 2026 · Filed June 03, 2026
Section 16 reporting ended · disclosed 2026-06-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 321,132 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Tax withholding · Disposed 8,519 · Balance 321,132 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2021 Filed Aug 4, 2021 20:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-005166 · primarydocument.xml · derivative · entry 6 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,948 Underlying: Common Stock · 1,100 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-005166 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,354 Underlying: Common Stock · 1,100 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 3,300 | $58.02 | $191,449.83 |
DisclosureSEC source: 0001562180-21-005166 · primarydocument.xml · nonDerivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,111 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $57.59 to $58.27 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $10.80 | $11,880.00 |
DisclosureSEC source: 0001562180-21-005166 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-21-005166 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 20:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $10.80 | $11,880.00 |
DisclosureSEC source: 0001562180-21-005166 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,050 | $10.80 Strike: $10.80 | $22,140.00 |
DisclosureSEC source: 0001562180-21-004818 · primarydocument.xml · derivative · entry 6 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,048 Underlying: Common Stock · 2,050 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $11.78 Strike: $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-21-004818 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,454 Underlying: Common Stock · 1,100 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 561 | $56.43 | $31,659.70 |
DisclosureSEC source: 0001562180-21-004818 · primarydocument.xml · nonDerivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,111 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F3 · price: Represents the weighted average sale price of the shares sold ranging from $56.37 to $56.54 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and footnote 2. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,699 | $55.75 | $150,457.10 |
DisclosureSEC source: 0001562180-21-004818 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,672 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F2 · price: Represents the weighted average sale price of the shares sold ranging from $55.34 to $56.27 per share, inclusive. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 2,050 | $10.80 | $22,140.00 |
DisclosureSEC source: 0001562180-21-004818 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 7, 2021 01:07 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-21-004818 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 00:23 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-004106 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,098 Underlying: Common Stock · 1,100 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 00:23 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-004106 · primarydocument.xml · derivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,554 Underlying: Common Stock · 1,100 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 00:23 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 3,186 | $52.77 | $168,140.51 |
DisclosureSEC source: 0001562180-21-004106 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,371 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $52.16 to $53.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 00:23 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-21-004106 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 00:23 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $10.80 | $11,880.00 |
DisclosureSEC source: 0001562180-21-004106 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 23:35 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 467 | $53.88 | $25,159.95 |
DisclosureSEC source: 0001562180-21-004060 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,357 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.66 to $54.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:39 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,255 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-003225 · primarydocument.xml · derivative · entry 7 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,198 Underlying: Common Stock · 1,255 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:39 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-003225 · primarydocument.xml · derivative · entry 6 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,453 Underlying: Common Stock · 1,100 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:39 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-003225 · primarydocument.xml · derivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,654 Underlying: Common Stock · 1,100 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:39 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 3,455 | $58.10 | $200,742.76 |
DisclosureSEC source: 0001562180-21-003225 · primarydocument.xml · nonDerivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,824 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $57.90 to $58.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:39 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $10.80 | $11,880.00 |
DisclosureSEC source: 0001562180-21-003225 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:39 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-21-003225 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:39 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,255 | $10.80 | $13,554.00 |
DisclosureSEC source: 0001562180-21-003225 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 950 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-002681 · primarydocument.xml · derivative · entry 8 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,553 Underlying: Common Stock · 950 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-002681 · primarydocument.xml · derivative · entry 7 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,754 Underlying: Common Stock · 1,100 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 19,999 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 945 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-002681 · primarydocument.xml · derivative · entry 6 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,854 Underlying: Common Stock · 945 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 19,999 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,706 | $47.60 | $128,803.71 |
DisclosureSEC source: 0001562180-21-002681 · primarydocument.xml · nonDerivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,824 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $47.10 to $47.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 392 | $48.16 | $18,877.70 |
DisclosureSEC source: 0001562180-21-002681 · primarydocument.xml · nonDerivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,530 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $48.15 to $48.16, inclusive. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 945 | $11.78 | $11,132.10 |
DisclosureSEC source: 0001562180-21-002681 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 950 | $10.80 | $10,260.00 |
DisclosureSEC source: 0001562180-21-002681 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:29 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-21-002681 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 00:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-002122 · primarydocument.xml · derivative · entry 7 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,799 Underlying: Common Stock · 1,100 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 19,999 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 00:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $11.78 | $0.00 |
DisclosureSEC source: 0001562180-21-002122 · primarydocument.xml · derivative · entry 6 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,899 Underlying: Common Stock · 1,100 shares Expires 2028-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 19,999 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 00:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 886 | $44.54 | $39,459.96 |
DisclosureSEC source: 0001562180-21-002122 · primarydocument.xml · nonDerivative · entry 5 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,927 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F4 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $44.04 to $45.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (4). Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 00:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,272 | $45.78 | $58,231.91 |
DisclosureSEC source: 0001562180-21-002122 · primarydocument.xml · nonDerivative · entry 4 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,813 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $45.22 to $46.06, inclusive. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 00:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 973 | $46.51 | $45,251.02 |
DisclosureSEC source: 0001562180-21-002122 · primarydocument.xml · nonDerivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,085 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $46.25 to $46.92, inclusive. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 00:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-21-002122 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 00:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,100 | $11.78 | $12,958.00 |
DisclosureSEC source: 0001562180-21-002122 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 16 | $49.63 | $794.05 |
DisclosureSEC source: 0001562180-21-001946 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,858 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · price: Represents the weighted average sale price of the shares sold ranging from $49.17 to $49.93 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 513 | $48.60 | $24,930.16 |
DisclosureSEC source: 0001562180-21-001946 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,874 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: Represents the weighted average sale price of the shares sold ranging from $48.15 to $49.06 per share, inclusive. Read SEC document |
| February 18, 2021 Filed Feb 23, 2021 01:36 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001421 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,387 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2021 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:44 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 496 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-21-000879 · primarydocument.xml · derivative · entry 3 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,503 Underlying: Common Stock · 496 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:44 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,717 | $49.15 | $84,389.69 |
DisclosureSEC source: 0001562180-21-000879 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,387 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $48.88 to $49.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote Read SEC document |
| February 01, 2021 Filed Feb 4, 2021 00:44 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 496 | $10.80 | $5,356.80 |
DisclosureSEC source: 0001562180-21-000879 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 485 | $42.61 | $20,664.73 |
DisclosureSEC source: 0001562180-21-000221 · primarydocument.xml · nonDerivative · entry 2 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,608 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $42.17 to $42.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,085 | $43.46 | $47,151.82 |
DisclosureSEC source: 0001562180-21-000221 · primarydocument.xml · nonDerivative · entry 1 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,093 F1 · kind: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 21, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $43.41 to $43.68, inclusive. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 01:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 260 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001562180-20-007423 · primarydocument.xml · derivative · entry 8 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 260 shares Expires 2023-08-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 1,250 shares underlying the options vested in an annual installment on June 17, 2014 and the remaining balance vested in equal monthly installments until the option vested in full on June 17, 2017. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 01:46 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $6.24 | $0.00 |
DisclosureSEC source: 0001562180-20-007423 · primarydocument.xml · derivative · entry 7 Llewelyn Linda · CIK 0001780878 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2024-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 500 shares underlying the options vested in an annual installment on May 13, 2015 and the remaining balance vested in equal monthly installments until the option vested in full on May 13, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.